Breaking News Instant updates and real-time market news.

CLVS

Clovis

$53.49

4.16 (8.43%)

16:59
01/12/17
01/12
16:59
01/12/17
16:59

Palo Alto Investors reports 9.86% passive stake in Clovis

  • 23

    Feb

CLVS Clovis
$53.49

4.16 (8.43%)

12/20/16
LEER
12/20/16
NO CHANGE
LEER
Outperform
Clovis Rubraca approval unlikely to impact TESARO niraparib, says Leerink
Commenting on Clovis' (CLVS) Rubraca accelerated approval by the FDA for the treatment of germline or somatic BRCA-mutated ovarian cancer patients, Leerink analyst Seamus Fernandez says the label appears "fairly broad" and does not restrict use based on platinum sensitivity/resistance. While he believes this current approval is unlikely to impact the initial competitive dynamics for TESARO's (TSRO) niraparib or AstraZeneca's (AZN) Lynparza in second-line maintenance, the analyst points out that data from Rubraca's Phase 3 ARIEL3 trial in this setting is now expected in mid-2017. Despite the earlier readout, Fernandez continues to see niraparib as the ultimate winner in second-line maintenance. He reiterates an Outperform rating on TESARO's shares.
12/20/16
BARD
12/20/16
NO CHANGE
Target $127
BARD
Outperform
TESARO outlook unchanged despite competitor approval, says Baird
Baird analyst Michael Ulz said his outlook for TESARO (TSRO) remains unchanged despite the approval of Clovis' (CLVS) ovarian cancer drug. The analyst said the Clovis drug approval was expected and believes its bodes well, as it highlights the FDA's favorable view toward PARP inhibitors. Ulz, who noted TESARO's drug is to be used as an earlier line of therapy, maintained his Outperform rating and $127 price target on TESARO shares.
12/21/16
JANY
12/21/16
NO CHANGE
Target $44
JANY
Neutral
Clovis price target raised to $44 from $38 at Janney Capital
Janney Capital analyst Debjit Chattopadhyay raised his price target for Clovis Oncology to $44 to reflect his assumption of $36M in Rubraca sales for FY17. Clovis is launching Rubraca in the U.S. with around 85 sales reps, and the analyst assumes a similar sized organization in the major European markets. He assumes Clovis launches the drug without a partner in Europe. He believes the FDA's position on competitor TESARO's (TSRO) niraparib will have implications for Clovis prior to the ARIEL3 data. Chattopadhyay keeps a Neutral rating on Clovis. The stock is up 8% to $45.86 in midday trading.
01/03/17
JANY
01/03/17
NO CHANGE
JANY
Janney sees pricing, rising rates as biotech headwinds in 2017
Janney Capital analyst Debjit Chattopadhyay noted that, on a relative basis vs. the Nasdaq, 2016 was the worst year for the Nasdaq biotechnology index (NBI) since 1994 and he believes the "outlook for 2017 isn't particularly rosy" given structural challenges for the sector along with rising interest rates. He cautions about overenthusiasm on M&A, as Chattopadhyay thinks "cash rich pharma may choose to return cash to shareholders through increased buybacks and dividends," and he believes "M&A, if any, is likely to lead to short-term relief rallies and may not represent a broader turn in sentiment." Meanwhile, broader discussion on healthcare spending and regulatory changes are likely to be bigger drivers of biotech sentiment during 2017 than M&A, said Chattopadhyay, who listed bluebird bio (BLUE), Galapagos NV (GLPG), Vertex (VRTX), Clovis (CLVS) and Nektar (NKTR) as on the firm's 2017 biotechnology focus list.

TODAY'S FREE FLY STORIES

13:45
12/13/17
12/13
13:45
12/13/17
13:45
General news
Breaking General news story  »

FOMC Forecasts to be…

13:45
12/13/17
12/13
13:45
12/13/17
13:45
General news
FOMC Meeting Announcement Federal Funds Rate to be reported at 14:00 »

FOMC Meeting Announcement…

TMUS

T-Mobile

$63.48

0.41 (0.65%)

13:44
12/13/17
12/13
13:44
12/13/17
13:44
Recommendations
T-Mobile analyst commentary  »

T-Mobile acquisition of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TNC

Tennant

$62.85

0.8 (1.29%)

13:43
12/13/17
12/13
13:43
12/13/17
13:43
Hot Stocks
Tennant says will 'carefully evaluate' views of shareholder PrimeStone »

Tennant Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$54.87

-0.34 (-0.62%)

13:40
12/13/17
12/13
13:40
12/13/17
13:40
Options
Notable call buying in Nektar as shares reach 52-week highs »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$11.01

0.135 (1.24%)

13:35
12/13/17
12/13
13:35
12/13/17
13:35
Options
Express put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

DBD

Diebold

$17.78

-0.725 (-3.92%)

13:22
12/13/17
12/13
13:22
12/13/17
13:22
Recommendations
Diebold analyst commentary  »

Diebold needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVG

Convergys

$24.12

0.15 (0.63%)

13:21
12/13/17
12/13
13:21
12/13/17
13:21
Conference/Events
Convergys management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

$NSD

NASDAQ Market Internals

13:17
12/13/17
12/13
13:17
12/13/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
12/13/17
12/13
13:16
12/13/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.48

-0.14 (-0.26%)

, EADSY

Airbus

$25.54

0.22 (0.87%)

13:15
12/13/17
12/13
13:15
12/13/17
13:15
Periodicals
Delta to place 'huge' jet order with Airbus, CNN says »

Delta Air Lines (DAL)…

DAL

Delta Air Lines

$53.48

-0.14 (-0.26%)

EADSY

Airbus

$25.54

0.22 (0.87%)

BA

Boeing

$293.91

3.97 (1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SBCF

Seacoast Banking

$25.52

0.21 (0.83%)

13:15
12/13/17
12/13
13:15
12/13/17
13:15
Conference/Events
Seacoast Banking management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HBI

Hanesbrands

$21.31

0.355 (1.69%)

13:15
12/13/17
12/13
13:15
12/13/17
13:15
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.49

-0.135 (-0.25%)

, BA

Boeing

$293.97

4.0261 (1.39%)

13:11
12/13/17
12/13
13:11
12/13/17
13:11
Periodicals
Delta to order about 100 jets from Airbus, CNN says »

Shares of Boeing (BA) are…

DAL

Delta Air Lines

$53.49

-0.135 (-0.25%)

BA

Boeing

$293.97

4.0261 (1.39%)

EADSY

Airbus

$25.54

0.22 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SAFM

Sanderson Farms

$167.00

1.08 (0.65%)

13:09
12/13/17
12/13
13:09
12/13/17
13:09
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NDSN

Nordson

$124.22

-0.8 (-0.64%)

, PIR

Pier 1 Imports

$5.80

0.34 (6.23%)

13:09
12/13/17
12/13
13:09
12/13/17
13:09
Earnings
Notable companies reporting after market close »

Notable companies…

NDSN

Nordson

$124.22

-0.8 (-0.64%)

PIR

Pier 1 Imports

$5.80

0.34 (6.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AMN

AMN Healthcare

$48.20

-0.1 (-0.21%)

13:09
12/13/17
12/13
13:09
12/13/17
13:09
Conference/Events
AMN Healthcare management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

DECK

Deckers Brands

$78.28

1.15 (1.49%)

13:06
12/13/17
12/13
13:06
12/13/17
13:06
Periodicals
Marcato poised to win in proxy battle with Deckers, Reuters reports »

Marcato Capital appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$81.66

-0.345 (-0.42%)

13:03
12/13/17
12/13
13:03
12/13/17
13:03
Hot Stocks
Medtronic pays $12M in multistate settlement over marketing »

Massachusetts will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$267.00

0.2237 (0.08%)

12:57
12/13/17
12/13
12:57
12/13/17
12:57
Periodicals
Trump says would sign tax bill with 21% corporate rate, CNBC reports 

Reference Link

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$267.00

0.2237 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIZ

Assurant

$99.77

-0.53 (-0.53%)

12:55
12/13/17
12/13
12:55
12/13/17
12:55
Conference/Events
Assurant management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$267.23

0.45 (0.17%)

12:48
12/13/17
12/13
12:48
12/13/17
12:48
Periodicals
Breaking Periodicals news story on S&P 500, SPDR S&P 500 ETF Trust »

Corporate AMT not in tax…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$267.23

0.45 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$61.60

0.39 (0.64%)

12:47
12/13/17
12/13
12:47
12/13/17
12:47
Conference/Events
LHC Group management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

TOSYY

Toshiba, also use TOSBF

$16.21

0.035 (0.22%)

, TOSBF

Toshiba, also use TOSYY

$2.69

0.004 (0.15%)

12:47
12/13/17
12/13
12:47
12/13/17
12:47
Upgrade
Toshiba, also use TOSBF, Toshiba, also use TOSYY rating change  »

Toshiba upgraded to Buy…

TOSYY

Toshiba, also use TOSBF

$16.21

0.035 (0.22%)

TOSBF

Toshiba, also use TOSYY

$2.69

0.004 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$21.65

-0.025 (-0.12%)

12:45
12/13/17
12/13
12:45
12/13/17
12:45
Conference/Events
Easterly Government Properties management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.